Orthofix Medical Stock Performance
| OFIX Stock | USD 11.24 0.26 2.26% |
The company holds a Beta of 1.88, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Orthofix Medical will likely underperform. At this point, Orthofix Medical has a negative expected return of -0.34%. Please make sure to check Orthofix Medical's maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and relative strength index , to decide if Orthofix Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Orthofix Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (2.26) | Five Day Return 2.55 | Year To Date Return (34.88) | Ten Year Return (66.18) | All Time Return 7.05 |
1 | Orthofix Reports First Quarter 2025 Financial Results | 05/06/2025 |
2 | Acquisition by Bazaar Alan Lee of 1990 shares of Orthofix Medical at 12.623 subject to Rule 16b-3 | 05/09/2025 |
3 | Acquisition by Bazaar Alan Lee of 2000 shares of Orthofix Medical at 12.586 subject to Rule 16b-3 | 05/12/2025 |
4 | Insider Spends US125k Buying More Shares In Orthofix Medical | 05/15/2025 |
5 | Acquisition by Bazaar Alan Lee of 2250 shares of Orthofix Medical at 10.92 subject to Rule 16b-3 | 06/04/2025 |
6 | Disposition of 1643 shares by Max Reinhardt of Orthofix Medical at 11.64 subject to Rule 16b-3 | 06/11/2025 |
7 | Orthofix Medical shareholders have endured a 67 percent loss from investing in the stock five years ago | 06/17/2025 |
8 | Disposition of 3728 shares by Aviva McPherron of Orthofix Medical at 10.51 subject to Rule 16b-3 | 06/18/2025 |
9 | Orthofix Medical Inc. Receives Average Rating of Moderate Buy from Analysts | 06/23/2025 |
10 | Orthofix Medical Inc. Insider Aviva Mcpherron Sells 3,728 Shares | 06/24/2025 |
11 | Acquisition by Engine Capital Management, Lp of 1250 shares of Orthofix Medical at 11.105 subject to Rule 16b-3 | 07/02/2025 |
12 | Blood Lead Analyzer Market Outlook 2025-2034 Stryker Launches Advanced Pediatric ESIN Systems, Orthofix and Smith Nephew Follow Suit | 07/10/2025 |
13 | Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference OFIX Stock News | 07/16/2025 |
14 | What drives Orthofix Medical Inc. stock price - Unmatched market gains - Jammu Links News | 07/18/2025 |
15 | What drives Orthofix Medical Inc. stock price - Superior capital gains - jammulinksnews.com | 07/22/2025 |
| Begin Period Cash Flow | 37.8 M | |
| Total Cashflows From Investing Activities | -27.6 M |
Orthofix Medical Relative Risk vs. Return Landscape
If you would invest 1,412 in Orthofix Medical on April 26, 2025 and sell it today you would lose (288.00) from holding Orthofix Medical or give up 20.4% of portfolio value over 90 days. Orthofix Medical is currently does not generate positive expected returns and assumes 2.5922% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Orthofix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Orthofix Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orthofix Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Orthofix Medical, and traders can use it to determine the average amount a Orthofix Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.131
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OFIX |
Estimated Market Risk
| 2.59 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Orthofix Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orthofix Medical by adding Orthofix Medical to a well-diversified portfolio.
Orthofix Medical Fundamentals Growth
Orthofix Stock prices reflect investors' perceptions of the future prospects and financial health of Orthofix Medical, and Orthofix Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Orthofix Stock performance.
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.05 | ||||
| Profit Margin | (0.18) % | ||||
| Operating Margin | (0.18) % | ||||
| Current Valuation | 585.39 M | ||||
| Shares Outstanding | 39.18 M | ||||
| Price To Earning | 338.00 X | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 0.55 X | ||||
| Revenue | 799.49 M | ||||
| Gross Profit | 552.45 M | ||||
| EBITDA | (34.18 M) | ||||
| Net Income | (126 M) | ||||
| Cash And Equivalents | 59.54 M | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 179.63 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 3.15 X | ||||
| Book Value Per Share | 11.72 X | ||||
| Cash Flow From Operations | 25.79 M | ||||
| Earnings Per Share | (3.70) X | ||||
| Market Capitalization | 440.39 M | ||||
| Total Asset | 893.29 M | ||||
| Retained Earnings | (276.14 M) | ||||
| Working Capital | 264.66 M | ||||
| Current Asset | 147.87 M | ||||
| Current Liabilities | 52.94 M | ||||
About Orthofix Medical Performance
Evaluating Orthofix Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Orthofix Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Orthofix Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 272.67 | 187.26 | |
| Return On Tangible Assets | (0.21) | (0.20) | |
| Return On Capital Employed | (0.12) | (0.11) | |
| Return On Assets | (0.14) | (0.13) | |
| Return On Equity | (0.25) | (0.24) |
Things to note about Orthofix Medical performance evaluation
Checking the ongoing alerts about Orthofix Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Orthofix Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Orthofix Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 799.49 M. Net Loss for the year was (126 M) with profit before overhead, payroll, taxes, and interest of 552.45 M. | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: What drives Orthofix Medical Inc. stock price - Superior capital gains - jammulinksnews.com |
- Analyzing Orthofix Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Orthofix Medical's stock is overvalued or undervalued compared to its peers.
- Examining Orthofix Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Orthofix Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Orthofix Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Orthofix Medical's stock. These opinions can provide insight into Orthofix Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.